| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |